Literature DB >> 27735036

miR-494 inhibits invasion and proliferation of gastric cancer by targeting IGF-1R.

X-Q Zhao1, T-J Liang, J-W Fu.   

Abstract

OBJECTIVE: The aim of this study was to investigate the target gene of miR-494 and its roles in tumor growth of gastric cancer (GC). PATIENTS AND METHODS: Expression of miR-494 was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) in gastric cancer tissues and cell lines. Then, luciferase reporter assay was used to elucidate whether insulin-like growth factor 1 receptor (IGF1R) is a target gene of miR-494. Finally, the roles and mechanism of miR-494 in the regulation of tumor invasion were further investigated.
RESULTS: Relative miR-494 level was found to be significantly lower in patients with GC than healthy controls (p < 0.01). Over-expression of miR-494 could inhibit gastric cancer cell proliferation, migration, and invasion in vitro. Furthermore, we demonstrated that miR-494 binds to the 3'-untranslated region (UTR) of IGF1R and inhibits the expression of the IGF1R protein.
CONCLUSIONS: Our data showed that miR-494 acted as a tumor suppressor in GC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27735036

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma.

Authors:  Shaowei Jiang; Ying Hu; Yi Zhou; Guozheng Tang; Wenxu Cui; Xinyi Wang; Bangjie Chen; Zuhong Hu; Bing Xu
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

2.  Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis.

Authors:  Dejie Lu; Hanji Huang; Li Zheng; Kanglu Li; Xiaofei Cui; Xiong Qin; Mingjun Zheng; Nanchang Huang; Chaotao Chen; Jinmin Zhao; Bo Zhu
Journal:  Comput Math Methods Med       Date:  2022-09-22       Impact factor: 2.809

3.  miR‑494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma.

Authors:  Wei Yuan; Du Wang; Yang Liu; Dongdong Tian; Yang Wang; Ranxi Zhang; Liangjun Yin; Zhongliang Deng
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

4.  miR-494 protects pancreatic β-cell function by targeting PTEN in gestational diabetes mellitus.

Authors:  Yanfang He; Jie Bai; Ping Liu; Jianxin Dong; Yajuan Tang; Jianli Zhou; Ping Han; Jun Xing; Yan Chen; Xiangyang Yu
Journal:  EXCLI J       Date:  2017-12-12       Impact factor: 4.068

5.  Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.

Authors:  Hui Wei; Kang Yu; Yongheng Liu; Lili Li; Guowen Wang
Journal:  BMC Cancer       Date:  2020-08-12       Impact factor: 4.430

6.  MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.

Authors:  Huiping He; Xianghui Liao; Qingmei Yang; Yuan Liu; Yan Peng; Hongzhen Zhong; Jun Yang; Huiqing Zhang; Zhonghua Yu; Yufang Zuo; Chengnong Guan; Zumin Xu
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

7.  MicroRNA-494 represses osteosarcoma development by modulating ASK-1 related apoptosis complexes.

Authors:  Gan Gao; Yuekui Jian
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.